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Abstract
Cough is one of the three major symptoms reported by chronic obstructive
pulmonary disease (COPD) patients. The Leicester Cough Questionnaire (LCQ)
is a questionnaire exploring the impact of cough, but it does not exist in French.
The aim of this study was to develop a French version of LCQ and to assess
its psychometrics properties. A forward-backward translation process was used
to develop the French version of the LCQ. COPD patients completed LCQ
and Cough and Sputum Assessment Questionnaire (CASA-Q) to determine
concurrent validity, content validity and internal consistency. Two weeks later, the
LCQ was repeated to evaluate the reproducibility. Seventy-four COPD patients
were recruited. The concurrent validity showed highly significant correlations
between all scores of LCQ and CASA-Q (p < 0.001). The content validity was
good with domain total scores correlations ranging from 0.918 to 0.953. The
LCQ domains and total scores showed a very good internal consistency with
Cronbach's...
Document type : Article de périodique (Journal article)
Référence bibliographique
Reychler, Gregory ; Schinckus, Mathilde ; Fremault, Antoine ; Liistro, Giuseppe ; Pieters, Thierry.
Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive
pulmonary disease. In: Chronic Respiratory Disease, Vol. 12, no. 4, p. 313-319 (2015)
DOI : 10.1177/1479972315602618
Original Article
Validation of the French version
of the Leicester Cough Questionnaire
in chronic obstructive pulmonary
disease
Reychler Gregory1,2,3, Schinckus Mathilde1,
Fremault Antoine4, Liistro Giuseppe1,2
and Pieters Thierry1,2
Abstract
Cough is one of the three major symptoms reported by chronic obstructive pulmonary disease (COPD) patients.
The Leicester Cough Questionnaire (LCQ) is a questionnaire exploring the impact of cough, but it does not exist
in French. The aim of this study was to develop a French version of LCQ and to assess its psychometrics
properties. A forward–backward translation process was used to develop the French version of the LCQ.
COPD patients completed LCQ and Cough and Sputum Assessment Questionnaire (CASA-Q) to determine
concurrent validity, content validity and internal consistency. Two weeks later, the LCQ was repeated to
evaluate the reproducibility. Seventy-four COPD patients were recruited. The concurrent validity showed
highly significant correlations between all scores of LCQ and CASA-Q (p < 0.001). The content validity was
good with domain total scores correlations ranging from 0.918 to 0.953. The LCQ domains and total scores
showed a very good internal consistency with Cronbach’s a coefficients ranging between 0.802 and 0.917.
The test–retest reliability was high in COPD patients with no change in cough. In conclusion, The French
version of the LCQ is a valid and reliable instrument to measure health status in COPD patients.
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Introduction
Nowadays, an approach integrating basic sciences,
psychosocial and economic parameters is promoted
in medicine. Assessing health-related quality of life
(HRQoL) helps the clinician to evaluate and quantify
the effects of disease on patients’ daily life. Today, it
is also an important tool in the evaluation of treat-
ment effect.1 Different questionnaires are available
for this purpose. They can be generic or specific to
a disease, and they measure parameters other than
strictly clinical.
In chronic diseases like chronic obstructive pul-
monary disease (COPD), specific questionnaires are
necessary to optimally target symptoms specific to the
disease condition, to explore their physical effects and
the subsequent restrictions in daily life and to evaluate
the effect of treatment.
QoL impairment is usually related to symptoms in
diseases as it was demonstrated in COPD.2 Moreover,
importance of symptoms in COPD is now highlighted
in the new classification of the Global Initiative for
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Chronic Obstructive Lung Disease (GOLD). Cough is
one of the three major symptoms reported by COPD
patients.3 Its importance evolves depending on the
stage of the disease.4
Surprisingly, cough is poorly studied in COPD. It is
probably due to the lack of valid evaluation tools.
Beside cough counters, some questionnaires include
items evaluating impact of cough on QoL. They are
more valid than cough diaries and visual analogue
scale because they measure a combination of aspects
of cough severity that include cough frequency and
intensity, mood and QoL.5 The Leicester Cough
Questionnaire (LCQ) is a validated HRQoL question-
naire initially developed for patients presenting
chronic cough.6 It explores the impact of cough sever-
ity across physical, psychological and social domains
and focuses specifically on cough contrarily to the
other questionnaires that encompass multiple respira-
tory symptoms. Its Dutch version was validated in
COPD patients,7 and its potential use was explored
in different conditions in this population.8–10
Unfortunately, no specific questionnaire exists in
French to evaluate cough as a single symptom. For
this purpose, the multilingual Cough and Sputum
Assessment Questionnaire (CASA-Q) seems the bet-
ter one as suggested by its name, and it includes eva-
luation of cough and sputum symptoms and their
impact in patients with COPD.11 Its psychometric
properties were assessed.12 It was validated in seven
languages including French.11 Nevertheless, LCQ
remains the international reference questionnaire for
cough evaluation. Then, it is interesting to have a
French version of this frequently used questionnaire.
The aim of this study was to validate the French
version of the LCQ as an assessment tool in COPD
patients.
Materials and methods
Ethics statement
The study was approved by the regional Ethics Com-
mittee in Cliniques Universitaires Saint-Luc and Uni-
versite´ Catholique de Louvain in Brussels (B4032
01317691). All the patients provided written informed
consent.
Subjects
COPD patients attending the pulmonology units of
Cliniques Universitaires Saint-Luc and of Grand
Hoˆpital de Charleroi were recruited on a voluntary
basis and without financial compensation for this
study. Consecutive patients fulfilling the inclusion
criteria were selected by the physician after approval
of the patients to enroll in the study.
The following inclusion criteria were used for both
phases of the study: a diagnostic of COPD associated
with the presence of cough and confirmed by spirome-
try according to GOLD criteria 2013, an age >18 years
and native French speaker (patients born in a franco-
phone family speaking French at home and living in
the francophone part of Belgium). The patients who
were unstable (defined by any modification of health
outcomes or treatment) after the inclusion in the study
were excluded from the second phase of the study.
Protocol
The study included two phases. During a routine visit,
the patients received both questionnaires LCQ and
CASA-Q. They were asked to fill out these question-
naires during the outpatient visit or at home using the
online version (phase I). They also received a second
package including only the LCQ. They were asked to
fill out this questionnaire 15 days later and then send
it back so that the responses obtained during the initial
visit could be compared with the later responses for
evaluating the LCQ reproducibility (phase II). For
paper and online versions of the questionnaires, com-
plete filling out of the items were checked. No assis-
tance in completing the questionnaires was provided.
Procedure
Permission to use and adapt the questionnaire was
obtained from its developers. The process was based on
Beaton’s guidelines.13 The original version of the LCQ
questionnaire was translated from English to French
using two bilingual translators with a medical back-
groundwhose primary language was French. From these
translated versions, any resulting issues were resolved to
obtain a complete agreement. The back translation of this
new version was performed by an independent English
native speaker. This translation was compared with the
original version and validated by authors of this article.
Finally, a pilot testing of this French version was per-
formed on six patients and one physiotherapist consider-
ing readability and comprehensiveness.
Leicester Cough Questionnaire
It is a 19-item, self-completed questionnaire as described
previously.6 It is divided into three domains and contains
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a seven-point Likert-type response scale for each item.
The LCQ score is calculated by aggregating the points
assigned to each question in each domain and then divid-
ing this total by the number of questions in the respective
domain. The total severity score ranges from 3 to 21 and
is calculated from 8, 7 and 4 items for physical, psycho-
logical and social domains, respectively. A lower score
indicates a greater impairment of health status due to
coughor sputum. It assesses the impact of symptomsover
the last two weeks.
Cough and Sputum Assessment Questionnaire
The CASA-Q is a multilingual questionnaire compris-
ing a French version. It was described elsewhere11
and includes 20 items assessing 4 hypothesized con-
cepts over the last 7 days: cough symptoms (COU-
SP), cough impact, sputum symptoms (SPUT-SP) and
sputum impact. Questions are answered on a scale
from ‘never’ to ‘always’ (for frequency) or from ‘not
at all’ to ‘a lot/extremely’ (for intensity). All items are
transformed to score from 1–5 or 0–4. Then, the
scores are reversed to obtain higher scores for better
responses. Within each domain, items are summed
and rescaled by calculating the sum of items score
divided by the range of rescored item sum and multi-
plied by 100. CASA-Q domain scores were obtained
ranging from 0 to 100. Higher scores were associated
with fewer symptoms/less impact due to cough or
sputum. No overall score was calculated.
Statistical analysis
The sample size needed (n ¼ 62) to compare LCQ to
CASA-Q (phase I) with a power of 80 was deter-
mined. The data were computed using SPSS 22.0
(IBM software) for Windows. A descriptive analysis
was performed for demographic parameters and for
the results of the questionnaires. Pearson correlation
between the scores for the domains from both instru-
ments was performed to determine the concurrent
validity which represents the instrument performance.
The content validity was verified by the correlation
between domain and total scores of the LCQ. The
internal consistency was assessed by Cronbach’s a
to determine the relationship between domains and
total scores of LCQ. Floor and ceiling effects were
verified if at least 15% of participants get to the low-
est or the highest score respectively in a particular
domain. The test–retest reliability was evaluated
using an intra-class coefficient (ICC) for total score
and for each item and domain of LCQ.14–16 Bias in the
LCQ scores and limits of agreement were estimated
using the Bland and Altman method. The effect size
was calculated for each domain and total scores by
calculating the mean of the differences between base-
line and follow-up scores and dividing this mean by
the standard deviation of these differences between
scores. All of the tests were two tailed, with a statisti-
cal significance level fixed at a p value of 0.05.
Results
Seventy-four consecutive patients (male/female ¼
43/31, age¼ 65.9+ 11.4 years and forced expiratory
volume in 1 second¼ 39.1+ 11.9% of pred.) met the
inclusion criteria and completed the LCQ French ver-
sion and the CASA-Q in phase I. The distribution of
patients was 15.8%, 57.9% and 26.3% between
GOLD groups 2, 3 and 4 respectively.
The domain and the total scores obtained in the
LCQ and the CASA-Q are presented in Table 1. The
concurrent validity showed highly significant cor-
relations between all scores of LCQ and CASA-Q
(p < 0.001; Table 2). Only Pearson coefficient
between psychological domain of LCQ and SPUT-
SP was weak (lower than 0.5). The content validity
and the internal consistency for LCQ are presented
in Table 3. The content validity was good with domain
total scores correlations ranging from 0.918 to 0.953.
They were all highly significant (p < 0.001). The LCQ
domains and total scores showed a very good internal
consistency with Cronbach’s a coefficients ranging
between 0.802 and 0.917.
The analysis of the scores distribution in our
patient population revealed an absence of ceiling and
floor effects for all of the domains of LCQ with less
Table 1. Scores obtained in both questionnaires.a
Questionnaire Domain Scores
LCQ Total 12.6 + 3.9 (4.4–20.5)
Physical 4.1 + 1.0 (1.8–6.5)
Psychological 4.2 + 1.5 (1.1–7.0)
Social 4.4 + 1.5 (1.0–7.0)
CASA-Q Cough symptom 47.2 + 22.0 (8.3–100)
Cough impact 52.9 + 25.2 (8.3–100)
Sputum symptom 48.7 + 20.0 (0–100)
Sputum impact 61.5 + 25.3 (0–100)
LCQ: Leicester Cough Questionnaire; CASA-Q: Cough and
Sputum Assessment Questionnaire; SD: standard deviation.
aResults are expressed as mean + SD (extremes values).
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than 8% of the patients having the lowest or highest
scores.
The test–retest reliability was evaluated on 24 sta-
ble COPD patients. ICCs were statistically significant
for total score and for each domain scores (Table 4
and Figure 1). The Bland and Altman method revealed
a low bias between the measurement days for the LCQ
total and domain scores (Table 5 and Figure 2). The
effect size was small for total LCQ (d¼ 0.11), psycho-
logical (d ¼ 0.03) and social (d ¼ 0.008) domains and
medium for physical domain (d ¼ 0.45).
Discussion
Based on the results of this study, we reported a good
concurrent and content validity and a good internal
consistency for the French version of LCQ. Moreover,
the test–retest reliability was verified for this trans-
lated version. These results confirm the validation
of the French version of the LCQ in COPD patients.
The results obtained to LCQ by our COPD patients
are in agreement with the validation of the initial LCQ
version in COPD patients.7 The CASA-Q scores
we found in our patients seem slightly worse than
CASA-Q scores measured 43 days after a treated
exacerbation in COPD patients.12 The concurrent
validity of the LCQ was very good between LCQ
and the CASA-Q scores with strong and statistically
significant correlations. Only the psychological domain
was moderately but highly significantly correlated to
SPUT-SP domain. The scientific value of this con-
current validity is particularly high. Indeed, contra-
rily to validations of other translations, we had the
opportunity to use a highly specific questionnaire
(CASA-Q) for the validation process. This question-
naire was previously validated for cough evalua-
tion.11 Even though a significant correlation was
found between all domains of LCQ and CASA-Q,
the hypothesized relationship of LCQ with sputum-
related domains of CASA-Q should be discussed.
Indeed, LCQ is specific to cough and its impact on
daily life, whilst CASA-Q includes two domains
related to sputum symptoms and their impact on daily
life. This difference probably explains the moderate
correlation we found between psychological domain
of LCQ and SPUT-SP domain of the CASA-Q.
However, sputum production is likely to mechani-
cally stimulate coughing17 on one hand, and sputum
wet weight was related to cough symptom evalua-
tion by COU-SP part of the CASA-Q11 on the other
hand, which justifies the investigation of this hypothe-
sized relationship.
The content validity of the questionnaire was
assessed by Pearson’s correlation coefficients between
domains and total score of LCQ. Values greater than
0.30 are associated with an acceptable result.18 The
content validity of the questionnaire was very good
with all of the coefficients higher than 0.90. The inter-
nal consistency was also excellent for all domains with
Cronbach’s a scores varying between 0.802 and 0.917
and exceeding 0.7, which is classically considered as
the acceptable cut-off for this purpose.19 Our results are
similar to the validations of this questionnaire in other
languages showing Cronbach’s a varying between 0.67
and 0.93.20,21.
Table 2. Concurrent validity.
CASA-Q
COU-SP COU-I SPUT-SP SPUT-I
LCQ Total 0.578 0.896 0.587 0.814
Physical
domain
0.580 0.841 0.637 0.785
Psychological
domain
0.504 0.801 0.454 0.700
Social domain 0.558 0.885 0.594 0.817
LCQ: Leicester Cough Questionnaire; CASA-Q: Cough and
Sputum Assessment Questionnaire. COU-SP: cough symptom;
COU-I: cough impact; SPUT-SP: sputum symptom; SPUT-I: spu-
tum impact.
Table 3. Content validity and internal consistency for
LCQ.
Correlation Cronbach’s a
Total 0.917
Physical 0.918 0.861
Psychological 0.943 0.805
Social 0.953 0.802
LCQ: Leicester Cough Questionnaire.
Table 4. Test–retest reliability for LCQ.
Domain LCQ ICC p Value
Total 0.85 <0.001
Physical 0.85 <0.001
Psychological 0.89 <0.001
Social 0.77 <0.001
LCQ: Leicester Cough Questionnaire; ICC: intra-class correla-
tion coefficient.
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Ceiling and floor effects occur when 15% or more
of the patients respond with a highest or lowest score,
respectively. Similar to the English LCQ validation
in COPD patients,7 we did not observe these effects
for any domain in our patients. Therefore, the validity
can be considered as acceptable with discriminative
extreme values.
The ICC for agreement was used to evaluate the
test–retest reliability. It is the most suitable reliability
parameter,19 and it is more adequate than the ICC for
consistency.14 Reliability is considered as good when
ICC is higher than 0.70.22 Test–retest reliability was
verified in our study for all of the domains and for the
total score. Moreover, using the Bland and Altman
method, we found bias of 0.27 and lower than
0.14 for total and domains scores, respectively. This
bias is lower than the bias measured for total score of
LCQ in its validation in COPD patients.7 The Bland
and Altman method23 is an adequate method to
observe absolute measurement errors between two
repetitive tests.19 Both instruments were administered
again after 2 weeks, considering that this period is
long enough to prevent the patients from remember-
ing the previous test but as short enough to avoid
changes in health status.
Figure 1. Test–retest reliability for total and domains scores of LCQ. LCQ: Leicester Cough Questionnaire.
Table 5. Bias and limits of agreement for the test–retest
reproducibility.
Bias
Limits of agreement
Lower Upper
Total 0.27 5.28 4.74
Physical 0.14 1.07 0.8
Psychological 0.02 1.68 1.73
Social 0.01 2.49 2.51
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The effect size (ES) quantifies the difference
between two measurements and is defined as small
(d < 0.2), small to moderate (d between 0.2 and
0.5), moderate to large (ES between 0.51 and 0.79),
and large (ES > 0.79).24 In our study, the the values
of ES were lower than 0.2 for all scores except for
psychological domain (d ¼ 0.45) highlighting good
agreement between the measurements.
Besides the intrinsic known weaknesses of the
questionnaires in general, one limitation of this study
is the use of a single questionnaire for the validation
process, but we believe that this limitation is coun-
tered by the specificity of the chosen questionnaire.
Moreover, the stability of the patients between both
administrations of the questionnaires could be dis-
cussed since it was only based on a subjective appre-
ciation. Finally, responsiveness remains to be tested.
However, all of the psychometric properties of a scale
cannot be established in a single study.25
In conclusion, the French version of LCQ is valid
for the evaluation of the cough in COPD patients
through GOLD stage 2 to 4. It was demonstrated by
a significant correlation with a validated specific
questionnaire related to symptoms and impact of
cough and sputum (CASA-Q). Moreover, the repro-
ducibility of the LCQ was verified in our sample of
COPD patients.
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